SCHEMBL6097892

SCHEMBL6097892

[CH2][C@@H]1CCCN1C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6097049 1.00
SCHEMBL1629962 1.00
SCHEMBL771599 0.93 CHRM2 (0.45)
SCHEMBL3746636 0.86
SCHEMBL3837925 0.77 DPP4 (0.42)
SCHEMBL27764348 0.77 DPP4 (0.42)
SCHEMBL6097746 0.77 RIPK1 (0.50)
SCHEMBL3863785 0.77 TSHR (0.45)
SCHEMBL27937090 0.77 EPHX2 (0.41)
SCHEMBL419842 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122580-B2 Aryl and heteroaryl compounds and methods to modulate coagulation TRANSTECH PHARMA, INC. (US) 2006-10-17 US claimed
EP-1546089-A2 ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION TransTech Pharma Inc. (US) 2005-06-29 EP claimed
US-20040110832-A1 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc TRANSTECH PHARMA, LLC 2004-06-10 US claimed
WO-2004014844-A2 ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION TRANSTECH PHARMA, INC. (US) 2004-02-19 WO claimed
CN-101535299-B 5-lipoxygenase-activating protein (flap) inhibitors PANMIRA PHARMACEUTICALS LLC 2013-09-25 CN disclosed